biospecimen_aliquot__bcr_aliquot_barcode	tcga-e2-a14o-01a-31d-a10y-09
biospecimen_aliquot__bcr_aliquot_uuid	d6ab6f8d-0e65-40a3-bf98-7249e4075395
biospecimen_aliquot__bcr_patient_uuid	fb356957-f620-4d99-b675-1355a1d9f932
biospecimen_aliquot__bcr_sample_barcode	tcga-e2-a14o-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0100490501
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.07
biospecimen_aliquot__date_of_shipment	2011-01-12
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	10
biospecimen_aliquot__plate_id	a10y
biospecimen_aliquot__plate_row	c
biospecimen_aliquot__quantity	1.82
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	26.00
biospecimen_analyte__a260_a280_ratio	1.87
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-e2-a14o-01a-31d
biospecimen_analyte__bcr_analyte_uuid	6eed560a-8a49-48be-9ba3-652138d02116
biospecimen_analyte__bcr_patient_uuid	fb356957-f620-4d99-b675-1355a1d9f932
biospecimen_analyte__bcr_sample_barcode	tcga-e2-a14o-01a
biospecimen_analyte__concentration	0.15
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	uv spec
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-e2-a14o
biospecimen_diagnostic_slides__bcr_patient_uuid	fb356957-f620-4d99-b675-1355a1d9f932
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-e2-a14o-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	432db252-35d4-4b02-b0a7-39bf85a38f89
biospecimen_normal_control__bcr_patient_barcode	tcga-e2-a14o
biospecimen_normal_control__bcr_patient_uuid	fb356957-f620-4d99-b675-1355a1d9f932
biospecimen_normal_control__ncedna_dna_conc	0.575
biospecimen_normal_control__ncedna_dna_qm	picogreen
biospecimen_normal_control__ncedna_dna_qty	20
biospecimen_normal_control__ncedna_dna_vol	35
biospecimen_portion__bcr_patient_uuid	fb356957-f620-4d99-b675-1355a1d9f932
biospecimen_portion__bcr_portion_barcode	tcga-e2-a14o-01a-31
biospecimen_portion__bcr_portion_uuid	3c11d81b-e3d1-443e-addc-d20f95c9c885
biospecimen_portion__bcr_sample_barcode	tcga-e2-a14o-01a
biospecimen_portion__date_of_creation	2010-12-23
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	31
biospecimen_portion__portion_sequence	3
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-e2-a14o-01a-31d
biospecimen_protocol__bcr_patient_uuid	fb356957-f620-4d99-b675-1355a1d9f932
biospecimen_protocol__bcr_sample_barcode	tcga-e2-a14o-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	fb356957-f620-4d99-b675-1355a1d9f932
biospecimen_sample__bcr_sample_barcode	tcga-e2-a14o-01a
biospecimen_sample__bcr_sample_uuid	565c78a9-ae5b-49ba-b5fa-4c26250e174a
biospecimen_sample__days_to_collection	1064
biospecimen_sample__initial_weight	210
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	false
biospecimen_sample__pathology_report_file_name	tcga-e2-a14o.42e9a561-b052-412e-b0fd-563dc097c3c5.pdf
biospecimen_sample__pathology_report_uuid	42e9a561-b052-412e-b0fd-563dc097c3c5
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_shipment_portion__bcr_patient_uuid	fb356957-f620-4d99-b675-1355a1d9f932
biospecimen_shipment_portion__bcr_sample_barcode	tcga-e2-a14o-01a
biospecimen_shipment_portion__bcr_shipment_portion_uuid	1b57149c-21de-43c8-8f92-f6adbd5623c3
biospecimen_shipment_portion__center_id	20
biospecimen_shipment_portion__is_ffpe	no
biospecimen_shipment_portion__plate_id	a13e
biospecimen_shipment_portion__portion_number	21
biospecimen_shipment_portion__portion_sequence	2
biospecimen_shipment_portion__shipment_portion_bcr_aliquot_barcode	tcga-e2-a14o-01a-21-a13e-20
biospecimen_shipment_portion__shipment_portion_day_of_shipment	22
biospecimen_shipment_portion__shipment_portion_month_of_shipment	3
biospecimen_shipment_portion__shipment_portion_year_of_shipment	2011
biospecimen_slide__bcr_patient_uuid	fb356957-f620-4d99-b675-1355a1d9f932
biospecimen_slide__bcr_sample_barcode	tcga-e2-a14o-01a
biospecimen_slide__bcr_slide_barcode	tcga-e2-a14o-01a-03-tsc
biospecimen_slide__bcr_slide_uuid	710a66c3-f0a8-4c93-85e9-6fd9906ae5f9
biospecimen_slide__image_file_name	tcga-e2-a14o-01a-03-tsc.710a66c3-f0a8-4c93-85e9-6fd9906ae5f9.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	2
biospecimen_slide__percent_monocyte_infiltration	0
biospecimen_slide__percent_necrosis	1
biospecimen_slide__percent_neutrophil_infiltration	0
biospecimen_slide__percent_normal_cells	0
biospecimen_slide__percent_stromal_cells	69
biospecimen_slide__percent_tumor_cells	30
biospecimen_slide__percent_tumor_nuclei	80
biospecimen_slide__section_location	top
biospecimen_tumor_sample__bcr_patient_barcode	tcga-e2-a14o
biospecimen_tumor_sample__bcr_patient_uuid	fb356957-f620-4d99-b675-1355a1d9f932
clinical_drug__bcr_drug_barcode	tcga-e2-a14o-d18524
clinical_drug__bcr_drug_uuid	4f298221-2d3f-4f83-8dbb-15844934baa0
clinical_drug__bcr_patient_barcode	tcga-e2-a14o
clinical_drug__bcr_patient_uuid	fb356957-f620-4d99-b675-1355a1d9f932
clinical_drug__form_completion_date	2011-10-20
clinical_drug__pharmaceutical_therapy_drug_name	arimidex
clinical_drug__pharmaceutical_therapy_type	hormone therapy
clinical_drug__pharmaceutical_tx_dose_units	mg/day
clinical_drug__pharmaceutical_tx_ongoing_indicator	yes
clinical_drug__pharmaceutical_tx_started_days_to	53
clinical_drug__pharmaceutical_tx_total_dose_units	mg/day
clinical_drug__prescribed_dose	1
clinical_drug__regimen_number	1
clinical_drug__route_of_administration	po
clinical_drug__therapy_regimen	adjuvant
clinical_drug__total_dose	1
clinical_follow_up__bcr_followup_barcode	tcga-e2-a14o-f18521
clinical_follow_up__bcr_followup_uuid	d8933de8-a517-4142-9c1d-e9cb01f4932f
clinical_follow_up__bcr_patient_barcode	tcga-e2-a14o
clinical_follow_up__bcr_patient_uuid	fb356957-f620-4d99-b675-1355a1d9f932
clinical_follow_up__followup_reason	scheduled follow-up submission
clinical_follow_up__form_completion_date	2011-10-19
clinical_follow_up__last_contact_days_to	1359
clinical_follow_up__new_tumor_event_dx_indicator	no
clinical_follow_up__radiation_treatment_adjuvant	yes
clinical_follow_up__targeted_molecular_therapy	yes
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_patient__age_at_diagnosis	76
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n1a
clinical_patient__ajcc_pathologic_tumor_stage	stage iiia
clinical_patient__ajcc_staging_edition	6th
clinical_patient__ajcc_tumor_pathologic_pt	t3
clinical_patient__anatomic_neoplasm_subdivision	left upper outer quadrant
clinical_patient__axillary_staging_method	sentinel lymph node biopsy plus axillary dissection
clinical_patient__bcr_patient_barcode	tcga-e2-a14o
clinical_patient__bcr_patient_uuid	fb356957-f620-4d99-b675-1355a1d9f932
clinical_patient__birth_days_to	-27837
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_positivity_method	allred score 5+3 = 8
clinical_patient__er_positivity_scale_other	allred score = 8
clinical_patient__er_status_by_ihc	positive
clinical_patient__ethnicity	not hispanic or latino
clinical_patient__form_completion_date	2011-3-31
clinical_patient__gender	female
clinical_patient__her2_cent17_ratio	1.65
clinical_patient__her2_fish_status	negative
clinical_patient__her2_ihc_percent_positive	50-59%
clinical_patient__her2_ihc_score	2+
clinical_patient__her2_status_by_ihc	equivocal
clinical_patient__histological_type	infiltrating ductal carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8500/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2008
clinical_patient__last_contact_days_to	1173
clinical_patient__lymph_nodes_examined	yes
clinical_patient__lymph_nodes_examined_count	18
clinical_patient__lymph_nodes_examined_he_count	2
clinical_patient__margin_status	negative
clinical_patient__menopause_status	post (prior bilateral ovariectomy or >12 mo since lmp with no prior hysterectomy)
clinical_patient__metastatic_tumor_indicator	no
clinical_patient__method_initial_path_dx	tumor resection
clinical_patient__micromet_detection_by_ihc	no
clinical_patient__patient_id	a14o
clinical_patient__pr_positivity_define_method	allred score 5+2 = 7
clinical_patient__pr_positivity_scale_other	allred score = 7
clinical_patient__pr_status_by_ihc	positive
clinical_patient__prospective_collection	no
clinical_patient__race	white
clinical_patient__retrospective_collection	yes
clinical_patient__surgical_procedure_first	modified radical mastectomy
clinical_patient__tissue_source_site	e2
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
clinical_radiation__bcr_patient_barcode	tcga-e2-a14o
clinical_radiation__bcr_patient_uuid	fb356957-f620-4d99-b675-1355a1d9f932
clinical_radiation__bcr_radiation_barcode	tcga-e2-a14o-r18525
clinical_radiation__bcr_radiation_uuid	c94602e4-7139-4008-bdc3-9058b35b1e21
clinical_radiation__course_number	1
clinical_radiation__form_completion_date	2011-10-20
clinical_radiation__radiation_adjuvant_units	cgy
clinical_radiation__radiation_therapy_ended_days_to	105
clinical_radiation__radiation_therapy_ongoing_indicator	no
clinical_radiation__radiation_therapy_site	primary tumor field
clinical_radiation__radiation_therapy_started_days_to	68
clinical_radiation__radiation_therapy_type	external beam
clinical_radiation__radiation_total_dose	5000
clinical_radiation__therapy_regimen	adjuvant
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-E2-A14O-01A-31D-A10Y-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-E2-A14O-01A-31D-A10Y-09.bed.meta
manually_curated__id	tcga-e2-a14o-01a-31d-a10y-09
manually_curated__md5sum	44770140e93ea34abe630f56273fec70
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	d6ab6f8d-0e65-40a3-bf98-7249e4075395
manually_curated__tumor_tag	brca
